Treace Medical Concepts (TMCI) Treasury Shares (2021 - 2026)

Treace Medical Concepts has reported Treasury Shares for 4 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 103.81% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 103.81% YoY), and the FY2025 full-year result was $1.2 million, up 321.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
• The five-year high for Treasury Shares was $248126.0 in Q1 2026, with the low at $356.0 in Q4 2024.
• Historically, Treasury Shares has averaged $76948.3 across 4 years, with a median of $47800.0 in 2024.
• Annual changes were most pronounced in 2024 — Treasury Shares jumped 2061.54% — and 2026, when it jumped 103.81%.
• Treace Medical Concepts' Treasury Shares stood at $13000.0 in 2023, then jumped by 2061.54% to $281000.0 in 2024, then jumped by 321.0% to $1.2 million in 2025, then grew by 17.5% to $1.4 million in 2026.
• The last three Treasury Shares figures came in at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.